Word

DGH

Status

Pending

Status Code

641

Status Date

Monday, June 24, 2024

Serial Number

98273074

Mark Type

4

Filing Date

Thursday, November 16, 2023

Trademark Owner History

KromaTiD Inc.

Classifications

5 Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Cells for medical use; Clinical medical reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Immunoassay reagents for medical use; Culture media for cultivating human blood cells; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes

44 DNA screening for medical purposes

42 Custom design and development of chemical reagents and biochemical assays; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research in the field of oncology; Medical research services; Scientific research; Scientific research and development; Scientific research consulting; Scientific research in the field of genetics and genetic engineering; Genetic testing for scientific research purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research for medical purposes in the area of cancerous diseases

Trademark Events

Nov 20, 2023

New Application Entered

Dec 21, 2023

New Application Office Supplied Data Entered

Jun 21, 2024

Assigned To Examiner

Jun 24, 2024

Notification Of Non-Final Action E-Mailed

Jun 24, 2024

Non-Final Action E-Mailed

Jun 24, 2024

Non-Final Action Written